A detailed history of American International Group, Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 23,050 shares of CARA stock, worth $7,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,050
Previous 23,248 0.85%
Holding current value
$7,606
Previous $17,000 17.65%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.52 - $1.05 $102 - $207
-198 Reduced 0.85%
23,050 $20,000
Q4 2023

Feb 13, 2024

SELL
$0.6 - $1.65 $56 - $155
-94 Reduced 0.4%
23,248 $17,000
Q3 2023

Nov 13, 2023

BUY
$1.67 - $3.33 $1,386 - $2,763
830 Added 3.69%
23,342 $39,000
Q2 2023

Aug 04, 2023

SELL
$2.83 - $4.94 $5,558 - $9,702
-1,964 Reduced 8.02%
22,512 $63,000
Q1 2023

May 12, 2023

BUY
$4.89 - $12.27 $518 - $1,300
106 Added 0.43%
24,476 $120,000
Q4 2022

Feb 10, 2023

SELL
$8.88 - $12.77 $1,704 - $2,451
-192 Reduced 0.78%
24,370 $261,000
Q3 2022

Nov 14, 2022

BUY
$8.24 - $12.56 $3,905 - $5,953
474 Added 1.97%
24,562 $230,000
Q2 2022

Aug 12, 2022

SELL
$7.45 - $13.84 $8,701 - $16,165
-1,168 Reduced 4.62%
24,088 $220,000
Q1 2022

May 13, 2022

SELL
$9.94 - $12.65 $15,794 - $20,100
-1,589 Reduced 5.92%
25,256 $307,000
Q4 2021

Feb 11, 2022

SELL
$11.99 - $18.14 $10,155 - $15,364
-847 Reduced 3.06%
26,845 $327,000
Q3 2021

Nov 12, 2021

SELL
$11.55 - $16.06 $11,942 - $16,606
-1,034 Reduced 3.6%
27,692 $428,000
Q2 2021

Aug 13, 2021

BUY
$12.38 - $29.19 $58,619 - $138,214
4,735 Added 19.74%
28,726 $410,000
Q1 2021

May 07, 2021

BUY
$15.07 - $21.71 $949 - $1,367
63 Added 0.26%
23,991 $521,000
Q4 2020

Feb 12, 2021

SELL
$12.72 - $16.16 $8,725 - $11,085
-686 Reduced 2.79%
23,928 $362,000
Q3 2020

Nov 04, 2020

SELL
$12.34 - $17.92 $6,922 - $10,053
-561 Reduced 2.23%
24,614 $313,000
Q2 2020

Aug 12, 2020

BUY
$12.39 - $17.33 $19,861 - $27,779
1,603 Added 6.8%
25,175 $430,000
Q1 2020

May 04, 2020

SELL
$9.12 - $17.78 $12,421 - $24,216
-1,362 Reduced 5.46%
23,572 $311,000
Q4 2019

Feb 05, 2020

SELL
$16.11 - $25.98 $3,399 - $5,481
-211 Reduced 0.84%
24,934 $402,000
Q3 2019

Nov 08, 2019

BUY
$18.28 - $26.91 $63,303 - $93,189
3,463 Added 15.97%
25,145 $460,000
Q2 2019

Aug 13, 2019

BUY
$17.68 - $21.57 $16,053 - $19,585
908 Added 4.37%
21,682 $466,000
Q1 2019

May 06, 2019

SELL
$14.41 - $19.64 $9,683 - $13,198
-672 Reduced 3.13%
20,774 $408,000
Q4 2018

Feb 13, 2019

SELL
$12.45 - $23.47 $2,041 - $3,849
-164 Reduced 0.76%
21,446 $279,000
Q3 2018

Nov 09, 2018

BUY
$17.57 - $23.95 $69,383 - $94,578
3,949 Added 22.36%
21,610 $518,000
Q2 2018

Aug 08, 2018

BUY
$11.6 - $19.27 $6,728 - $11,176
580 Added 3.4%
17,661 $338,000
Q1 2018

May 07, 2018

SELL
$11.77 - $16.08 $10,804 - $14,761
-918 Reduced 5.1%
17,081 $211,000
Q4 2017

Feb 09, 2018

BUY
$11.86 - $14.08 $1,008 - $1,196
85 Added 0.47%
17,999 $220,000
Q3 2017

Nov 09, 2017

BUY
$12.6 - $16.34 $225,716 - $292,714
17,914
17,914 $245,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.